trial · primary record
fostamatinib
Lung Transplantation
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 30 |
| Primary completion | 2028-07-14 |
| Primary endpoint | Study Drug Discontinuation Rate. |
| Registry ID | NCT06948097 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:16.535Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06948097
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.